|
|
Volumn 56, Issue 1, 2001, Pages 11-16
|
|
Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
ANTIINFECTIVE AGENT;
CLARITHROMYCIN;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
LANSOPRAZOLE;
OMEPRAZOLE;
PROTON PUMP;
TINIDAZOLE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHI SQUARE DISTRIBUTION;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
DRUG COMBINATION;
FEMALE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
MALE;
MICROBIOLOGY;
MIDDLE AGED;
PEPTIC ULCER;
STATISTICAL MODEL;
TREATMENT OUTCOME;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-BACTERIAL AGENTS;
CHI-SQUARE DISTRIBUTION;
CLARITHROMYCIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
FEMALE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
LOGISTIC MODELS;
MALE;
MIDDLE AGED;
OMEPRAZOLE;
PEPTIC ULCER;
PROTON PUMPS;
TINIDAZOLE;
TREATMENT OUTCOME;
|
|
EID: 0035229585
PISSN: 00418781
EISSN: None
Source Type: Journal
DOI: 10.1590/S0041-87812001000100003 Document Type: Article |
|
Times cited : (16)
|
|
References (0)
|
